Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SGMS2 | Q8NHU3 | 5/20 | 0.53 |
| ▸ | NPC1 | O15118 | 1/20 | 0.51 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 3/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | BRD4 | O60885 | 1/20 | 0.48 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30104115 | 0.85 | HCRTR1 (0.54) | GAAMEN1KMT2ALMNAMAPT | |
| SCHEMBL9643397 | 0.81 | SGMS2 (0.60) | SGMS2NPC1GAAMEN1KMT2A | |
| SCHEMBL27981110 | 0.81 | CTSD (0.51) | NPC1GAAKMT2ALMNAMAPT | |
| SCHEMBL548028 | 0.81 | LRRK2 (0.53) | LMNAALDH1A1 | |
| SCHEMBL9805921 | 0.79 | SGMS2 (0.57) | SGMS2NPC1GAAMEN1KMT2A | |
| SCHEMBL978857 | 0.78 | HTT (0.64) | SGMS2NPC1GAAMEN1KMT2A | |
| SCHEMBL9642440 | 0.78 | SGMS2 (0.59) | SGMS2NPC1GAAMEN1KMT2A | |
| SCHEMBL4879716 | 0.78 | SGMS2 (0.56) | SGMS2NPC1GAAMEN1KMT2A | |
| SCHEMBL1097809 | 0.78 | SGMS2 (0.59) | SGMS2NPC1GAAMEN1KMT2A | |
| SCHEMBL10443318 | 0.77 | SGMS2 (0.58) | SGMS2NPC1GAAMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2045014-B1 | POLYMER-SUPPORTED METAL COMPLEX CATALYST | UNIV HOKKAIDO NAT UNIV CORP (JP) | 2014-01-15 | — | — | EP | disclosed |
| US-8092720-B2 | Polymer-supported metal complex catalyst | NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY (JP) | 2012-01-10 | — | — | US | disclosed |
| US-8092720-B2 | Polymer-supported metal complex catalyst | NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY (JP) | 2012-01-10 | — | — | US | disclosed |
| US-20090227743-A1 | POLYMER-SUPPORTED METAL COMPLEX CATALYST | NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY (JP) | 2009-09-10 | — | — | US | disclosed |
| US-20090227743-A1 | POLYMER-SUPPORTED METAL COMPLEX CATALYST | NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY (JP) | 2009-09-10 | — | — | US | disclosed |
| EP-2045014-A1 | POLYMER-SUPPORTED METAL COMPLEX CATALYST | National University Corporation Hokkaido University (JP) | 2009-04-08 | — | — | EP | disclosed |
| US-7385064-B1 | Catalysts for use in enantioselective synthesis | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK | 2008-06-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090227743-A1 | POLYMER-SUPPORTED METAL COMPLEX CATALYST | PYM1, ARG1, SCO2 | SGMS2 2733/4885NPC1 4551/4885GAA 4499/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.